CAT No: CP01009
CAS No:65057-34-3
Synonyms/Alias:65057-34-3;Dicyclohexylamine(S)-2-((tert-butoxycarbonyl)amino)-3-(1-tosyl-1H-imidazol-4-yl)propanoate;AC1O5ALA;Boc-His(Toc)-OH.DCHA;15507_ALDRICH;15507_FLUKA;C30H46N4O6S;CTK2F6671;MolPort-003-926-824;EINECS265-328-0;9956AB;AKOS016010084;Boc-His(Tos)-OHdicyclohexylaminesalt;N-(tert-Butoxycarbonyl)-1-(p-tosyl)-L-histidine,compoundwithdicyclohexylamine(1:1);AK115073;AM001829;ST2419224;Boc-His(Tos)-OH(dicyclohexylammonium)salt;FT-0640989;3B3-051402;Nalpha-Boc-N(im)-tosyl-L-histidinedicyclohexylaminesalt;Nalpha-Boc-N(im)-tosyl-L-histidine(dicyclohexylammonium)salt;N-alpha-t-Butyloxycarbonyl-n-Im-t-tosyl-L-histidinedicyclohexylamine;(2S)-2-[(TERT-BUTOXYCARBONYL)AMINO]-3-[1-(4-METHYLBENZENESULFONYL)IMIDAZOL-4-YL]PROPANOICACID;DICHA
1. Implications of ligand-receptor binding kinetics on GLP-1R signalling
3. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.